Private Equity

Critical guidance on your journey

In the increasingly competitive environment of private equity, great deals are harder to find and the exceptional risk becomes the rule. With deep expertise across many industries and 800+ professionals providing M&A, growth equity and ECM, debt advisory and corporate finance services globally, we deliver a deal flow consisting of the very best opportunities on the market — and help you gain the upper hand.

Contact advisor

Worldwide

1,385

deals closed in Private Equity

Worldwide

Explore all our industry-related deals

Go to deals

BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher

Private Equity | Other Industries

BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher

BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.

Learn more

Admen, UAB has been acquired by Orion Private Equity

Private Equity | Other Industries

Admen, UAB has been acquired by Orion Private Equity

The private owners of Admen, UAB have sold a 44% stake in the company to Orion Private Equity, including 4% of newly issued capital.

Learn more

DPC has been acquired by Innova/6 SCA SICAV-RAIF

Private Equity | Healthcare

DPC has been acquired by Innova/6 SCA SICAV-RAIF

Innova/6 SCA SICAV-RAIF has acquired stakes in three companies operating in the dental services market in Central and Eastern Europe – the Lithuanian chain Clinic DPC and Polish Dentaurus and Medicadent clinics. Innova, in cooperation with the founding doctors, will develop a leading, independent regional dental group.

Learn more

“The unique blend of personality and professionalism made Oaklins’ team the perfect partner in this transaction. They became a natural extension of our own team, masterfully guiding us through the many turns and pivots of this complicated transaction. Their wide international reach and deep local knowledge was the key winning combination that led us to choose them from the many competing offers and remains the reason to recommend them for any future M&A deal. ”

Alexander Sasha Kelberg

Founder and CEO, GroGlass

Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=BAL&includes=featured_images,tags&language=en&limit=1&tags=private-equity

Reshaping industries: M&A highlights and strategic vision

QUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the adaptability of various industries to evolving market conditions and strategic imperatives.

Learn more